================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
March 10, 2006
Date of Report (Date of earliest event reported)
----------
ZYMOGENETICS, INC.
(Exact name of registrant as specified in its charter)
Washington 0-33489 91-1144498
(State or other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification Number)
1201 Eastlake Avenue East
Seattle, Washington 98102-3702
(Address of principal executive offices) (Zip Code)
206-442-6600
(Registrant's telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS
On March 10, 2006, Judith A. Hemberger, Ph.D. was appointed to the
ZymoGenetics, Inc. Board of Directors. Dr. Hemberger is not serving on any
committees of the Board of Directors at this time.
A press release announcing the election of Dr. Hemberger, dated March 13,
2006, is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits.
99.1 Press Release issued March 13, 2006 by ZymoGenetics, Inc.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
ZYMOGENETICS, INC.
Date: March 14, 2006 By: /s/ JAMES A. JOHNSON
-------------------------
Name: James A. Johnson
Title: Senior Vice President and
Chief Financial Officer
EXHIBIT INDEX
Exhibit Number Document Description
-------------- ---------------------------------------------------------
99.1 Press release issued March 13, 2006 by ZymoGenetics, Inc.